Who are Sinovac Biotech Ltd.'s main suppliers?

Sinovac Biotech Ltd. (SVA) key suppliers include: SBMFF, Abbott Laboratories, Abbott Laboratories, IAALF, IAALF and 6 more. View the full supplier network at chainsifter.com/chain/SVA.

Who are Sinovac Biotech Ltd.'s major customers?

Sinovac Biotech Ltd. (SVA) key customers include: Abbott Laboratories, Abbott Laboratories, IAALF, IAALF, PetroChina Company Limited and 13 more. View the full customer network at chainsifter.com/chain/SVA.

What sector is Sinovac Biotech Ltd. in?

Sinovac Biotech Ltd. (SVA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Sinovac Biotech Ltd. Suppliers, Customers & Supply Chain (SVA)

11Suppliers

18Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Sinovac Biotech Ltd. (SVA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

31Total relationships

2Distinct source URLs

3High confidence

0.712Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Sinovac Biotech Ltd. Suppliers

Ticker	Name	Confidence	Evidence
SBMFF	SBMFF	80%	Reciprocal relationship from SBMFF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from SBMFF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from SBMFF …
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from SVA graph: bined with greater affordability relative to comparable products offered by multinational competitors. Our ability to s…
ABT	Abbott Laboratories	72%	bined with greater affordability relative to comparable products offered by multinational competitors. Our ability to sustain this positioning also depends on our capacity to adapt promptly to China'…
IAALF	IAALF	72%	Reciprocal relationship from IAALF graph: Reciprocal relationship from SVA graph: on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We an…
IAALF	IAALF	72%	on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We analyze accounts receivable and historical bad debts, customer concentrations, custo…
PCCYF	PetroChina Company Limited	72%	on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We analyze accounts receivable and historical bad debts, customer concentrations, custo…
PCCYF	PetroChina Company Limited	72%	Reciprocal relationship from PCCYF graph: Reciprocal relationship from SVA graph: on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We an…
QFIN	Qfin Holdings, Inc.	72%	Reciprocal relationship from QFIN graph: odel to predict default rate for each loan portfolio. For external factors, we use projections commonly used within the industry. For internal factors, we mak…
SBMFF	SBMFF	72%	ty's patent; • a court may prohibit us from selling or licensing our product unless we obtain a license from the patent holder, which may not be available on commercially reasonable terms, if at all,…
SNYNF	Sanofi	72%	bined with greater affordability relative to comparable products offered by multinational competitors. Our ability to sustain this positioning also depends on our capacity to adapt promptly to China'…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SVA graph: bined with greater affordability re…

Sinovac Biotech Ltd. Customers

Ticker	Name	Confidence	Evidence
ABT	Abbott Laboratories	72%	artment of Health and Human Services. NIH has granted us a non-exclusive license to import and use certain Rotavirus Strains and Monoclonal Antibodies ("Biological Materials") to develop an oral rota…
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from SVA graph: artment of Health and Human Services. NIH has granted us a non-exclusive license to import and use certain Rotavirus St…
IAALF	IAALF	72%	on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We analyze accounts receivable and historical bad debts, customer concentrations, custo…
IAALF	IAALF	72%	Reciprocal relationship from IAALF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from IAALF graph: Reciprocal relationship from SVA graph: on our assessment of the collectabi…
PCCYF	PetroChina Company Limited	72%	on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We analyze accounts receivable and historical bad debts, customer concentrations, custo…
PCCYF	PetroChina Company Limited	72%	Reciprocal relationship from PCCYF graph: Reciprocal relationship from SVA graph: on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. We an…
SBMFF	SBMFF	72%	livelihood and major public interests, shall be subject to stricter management system. In addition, we may need to comply with increasingly complex and rigorous regulatory standards enacted to protec…
SBMFF	SBMFF	72%	Reciprocal relationship from SBMFF graph: Reciprocal relationship from SVA graph: livelihood and major public interests, shall be subject to stricter management system. In addition, we may need to co…
SNYNF	Sanofi	72%	artment of Health and Human Services. NIH has granted us a non-exclusive license to import and use certain Rotavirus Strains and Monoclonal Antibodies ("Biological Materials") to develop an oral rota…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SVA graph: Reciprocal relationship from SNYNF …
VXRT	Vaxart, Inc.	72%	Reciprocal relationship from VXRT graph: Reciprocal relationship from SVA graph: Reciprocal relationship from VXRT graph: Reciprocal relationship from SVA graph: Reciprocal relationship from VXRT gra…
CGEN	Compugen Ltd.	62%	Reciprocal relationship from CGEN graph: Reciprocal relationship from SVA graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from SVA graph: Reciprocal relationship from CGEN gra…
CHANGCHUN-CHANGSHENG-LIFE-SCIENCE-CO-LTD	CHANGCHUN-CHANGSHENG-LIFE-SCIENCE-CO-LTD	62%	uisition of new production lines, technologies, businesses, products or services or the creation of strategic alliances in areas in which we do not currently operate. These acquisitions and strategic…
DALIAN-JIN-GANG-GROUP	DALIAN-JIN-GANG-GROUP	62%	, and also have provided counter guarantees to Sinovac Life Science proportionately with respect to its loan guarantee. On April 24, 2026, the Company approved Sinovac Hong Kong to provide a loan of …
HUALAN-VACCINE-INC	HUALAN-VACCINE-INC	62%	artment of Health and Human Services. NIH has granted us a non-exclusive license to import and use certain Rotavirus Strains and Monoclonal Antibodies ("Biological Materials") to develop an oral rota…
PASSIVE-FOREIGN-INVESTMENT-COMPANY	PASSIVE-FOREIGN-INVESTMENT-COMPANY	62%	uisition of new production lines, technologies, businesses, products or services or the creation of strategic alliances in areas in which we do not currently operate. These acquisitions and strategic…
PUKANG-BIOLOGICAL-CO-LTD	PUKANG-BIOLOGICAL-CO-LTD	62%	artment of Health and Human Services. NIH has granted us a non-exclusive license to import and use certain Rotavirus Strains and Monoclonal Antibodies ("Biological Materials") to develop an oral rota…
U-S-INVESTMENT-COMPANY	U-S-INVESTMENT-COMPANY	62%	uisition of new production lines, technologies, businesses, products or services or the creation of strategic alliances in areas in which we do not currently operate. These acquisitions and strategic…

Sinovac Biotech Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
SVA-DEBT	Debt stack $498.2M	90%	Market cache reports total debt of $498.2M.

Sinovac Biotech Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sinovac Biotech Ltd..

Sinovac Biotech Ltd. Ownership

Holder	Name	Confidence	Evidence
SVA-OWNER-VIVO-CAPITAL-LLC	Vivo Capital, LLC	90%	13F overlay lists Vivo Capital, LLC as top holder; 29 tracked holders.

Sinovac Biotech Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ATOS	Atossa Therapeutics, Inc.	100.00	2
GCTK	GlucoTrack, Inc.	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
CHKIF	China Southern Airlines Company Limited	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
GRAL	GRAIL, Inc.	100.00	2
ALVO	Alvotech	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
CALC	CalciMedica, Inc.	100.00	2

Sinovac Biotech Ltd. Supply Chain